Vanzacaftor-Tezacaftor as an alternative therapeutic resource for the ETI-Resistant L467F-F508del Allele: Ex vivo prediction and exploratory clinical assessment
Fields of Study & Subjects
Cystic Fibrosis Research Advances
Asthma and respiratory diseases
Respiratory and Cough-Related Research
Publication details
- Journal / source
- Journal of Cystic Fibrosis
- Publisher
- Elsevier BV
- Volume
- 25
- Issue
- 5
- Pages
- 918–924
- Publication date
- 4 June 2026
- Language
- EN